Hamilton Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Hamilton Capital's LLY Position: Q1 2026 in Review
Hamilton Capital reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $169K and leaving 998 shares worth $918K. The position accounts for 0.05% of the portfolio, ranked #47.
Hamilton Capital first reported a position in LLY in Q3 2021 and has held it in 18 quarters since. The position peaked at $1.25M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Hamilton Capital held 998 shares of Eli Lilly worth $918K as of Q1 2026.
- Hamilton Capital sold 167 Eli Lilly shares in Q1 2026, an estimated $169K.
- Eli Lilly made up 0.05% of Hamilton Capital's portfolio in Q1 2026, its #47 holding.
- Hamilton Capital first reported a position in Eli Lilly in Q3 2021 and has held it in 18 quarters since.
- Hamilton Capital's Eli Lilly position peaked at $1.25M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Hamilton Capital's 13F filing for Q1 2026, filed 15 May 2026.